Science and Enterprise

Tag: NIH

  • NIH Awards $1.8 Million in Small Business Grants for Vaccines

    Altravax Inc. in Fargo, North Dakota received two grants from National Institutes of Health (NIH) for research on vaccines for HIV-1. A third NIH grant supports the company’s work on vaccines for an influenza virus. All three grants, valued at $1.8 million, are awarded under NIH’s Small Business Innovation Research (SBIR) program. Two of the…

  • Small Business Grant Awarded for Oral Hygiene Drug

    PolyMedix Inc., a biotechnology company in Radnor, Pennsylvania received a $986,000  Phase 2 small business grant from National Institutes of Health (NIH). The grant supports development of  antimicrobial compounds for the treatment of oral candidiasis, a yeast infection affecting the lining of the mouth or tongue, through 31 August 2012. Under the first portion of…

  • Trial Shows Genital Herpes Vaccine Ineffective for Women

    The National Institute of Allergy and Infectious Diseases (NIAID), part of National Institutes of Health in Bethesda, Maryland, reports that an experimental vaccine to prevent genital herpes disease in women, proved ineffective when tested in a recently concluded clinical trial. GlaxoSmithKline (GSK) Biologicals, based in Belgium, developed the vaccine it calls Simplirix. GSK announced today…

  • NIH Foundation, Eli Lilly Launch US-Russia Science Partnership

    The Foundation for the National Institutes of Health (FNIH) in Bethesda, Maryland and Eli Lilly and Company in Indianapolis, Indiana have started a U.S.–Russia Forum in Health Sciences to encourage collaboration on shared priorities in health related research. FNIH is establishing the forum with a $1.3 million grant from Eli Lilly as the founding private…

  • NIH Awards Two Small Business Grants for Skin Disorders

    Signum Biosciences Inc. in Princeton, New Jersey received two Small Business Innovation Research (SBIR) Phase 1 grants by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a division of the NIH, totaling over $684,000 for development of G-protein coupled receptor modulating therapeutics designed to treat common skin disorders. Phase 1 SBIR grants fund…

  • Robotic Catheter to Treat Cardiac Condition in Development

    Researchers from North Carolina State University (NC State) in Raleigh are developing a computerized catheter designed to make the surgical treatment of atrial fibrillation faster, cheaper, and more effective.  The device can also decrease a patient’s radiation exposure related to the treatment. Atrial fibrillation occurs when random electrical activity occurs in the upper chambers of…

  • BP Offers $10 Million to NIH for Gulf Health Research

    The oil producer BP said today it is providing $10 million to the National Institutes of Health (NIH) under its Gulf of Mexico Research Initiative (GRI) to support a study of potential public health issues relating to the Gulf oil spill and other spill-related health research. The GRI is a 10-year, $500 million independent research…

  • Small Business Grant Given for Cancer Drug Delivery System

    Celsion Corp., a biotechnology drug development company in Columbia, Maryland, has received a Phase 1 Small Business Innovation and Research (SBIR) grant from the National Institutes of Health. This funding will help the company develop its heat-activated liposomal — encapsulated cellular membrane sac — technology in combination with carboplatin, a frequently used oncology drug for…

  • HHS Review Highlights Role of Business in Medical Countermeasures

    The Department of Health and Human Services (HHS) today released a report on the federal government’s system to produce medications, vaccines, equipment, and supplies needed to meet a health emergency. The report — Public Health Emergency Medical Countermeasure Enterprise Review: Transforming the Enterprise to Meet Long Range National Needs — reviews the process and makes…

  • Small Business Grant Given for Recurrent Sarcoma Vaccine

    MabVax Therapeutics Inc., a biotechnology company in San Diego, California received a Small Business Innovation Research grant from the National Cancer Institute (NCI). The grant will support a Phase II clinical trial with 134 metastatic sarcoma — cancer of connective or supportive tissue — patients in a randomized, multicenter, double-blind study of a vaccine developed…